
Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBmVHpOSXJobTdYdzNQZFRYbkFPUFZSS1J0cjU3VHliLUFuTFB1c3pob0lXTkdyQVU2TDdWbWl3OFhGRWlCTzQ0Qmthb19tUGxjVUVka0N0em9zRHVMbTdV?oc=5" target="_blank">Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
